Scientific foundations / Molecular recognition
Antibodies & Immunodetection
Antibody-based methods make molecular recognition useful in the laboratory. Explore how antibodies recognise targets, how different detection methods generate signals and why validation must reflect the experiment being performed.
Immunodetection uses antibodies to investigate selected molecules in biological samples. A meaningful result depends on the relationship between the antibody, its target, the sample preparation and the detection system.
01 / Antigen recognition and epitopes
An antibody recognises a molecular feature called an epitope. For protein targets, this feature may involve a short sequence or a surface created by the folded protein. Recognition therefore depends on more than the target’s name: the relevant structure must be present and accessible under the experimental conditions.
This explains why an antibody can behave differently across methods. A preparation that unfolds proteins may expose one epitope while disrupting another. Interpretation begins by connecting the expected recognition event with the way the sample is prepared.
02 / Antibody formats and their practical differences
Antibody formats describe different aspects of a reagent. Monoclonal antibodies originate from a single clone, whereas polyclonal preparations contain a mixture of antibodies. Recombinant production describes a defined expression approach and can be used to produce sequence-defined antibodies.
These labels should guide evaluation rather than replace it. A format alone does not establish specificity, sensitivity or suitability for a particular application. Performance evidence for the intended sample and method remains essential.
| Description | Main characteristic | Evaluation priority |
|---|---|---|
| Monoclonal | Single-clone origin | Epitope accessibility and application evidence |
| Polyclonal | Mixed antibody population | Background, cross-reactivity and lot consistency |
| Recombinant | Production from defined genetic constructs | Sequence identity and demonstrated performance |
03 / Sample preparation shapes recognition
Fixation, permeabilisation, extraction and denaturation alter the environment in which an antibody encounters its target. A tissue section, a cell lysate and a purified protein preparation present different experimental conditions, even when the same protein is being studied.
For example, evidence from a denaturing immunoblot does not establish performance in fixed cells. Documentation should identify the preparation and conditions used. Transferring a reagent to another method requires evaluation within that new context.
04 / Primary recognition and detection systems
The primary antibody recognises the target. Detection may use a label attached directly to that antibody or a secondary reagent that recognises the primary antibody. Fluorescent labels and enzyme-based systems provide different ways to turn binding into a measurable signal.
In indirect detection, the secondary reagent must match the primary antibody’s host species and the appropriate immunoglobulin class or subclass. Its label must also suit the instrument and assay chemistry. These choices should be considered together, particularly in experiments detecting several targets.
05 / Immunodetection methods provide different information
Immunoblotting, immunofluorescence and ELISA share antibody-based recognition but organise the measurement differently. Choosing between them starts with the information needed: separation by apparent size, spatial distribution or analyte concentration.
| Method | Typical information | Important limitation |
|---|---|---|
| Western blot | Immunoreactive bands after protein separation | Expected band size alone does not establish identity |
| Immunofluorescence | Distribution of labelled targets | Localisation depends on specificity and preparation |
| ELISA | Assay-defined analyte measurement | Sample effects and calibration influence quantification |
| Flow cytometry | Labelled characteristics of individual events | Controls, sample preparation and gating affect interpretation |
Complementary methods can strengthen an investigation because they examine different properties. Agreement should be interpreted in light of what each assay actually measures, rather than assuming that every antibody-based signal represents the same observation.
06 / Validation belongs to the application
Antibody validation examines whether a reagent supports its intended interpretation in a specified experiment. Uhlen and colleagues proposed complementary approaches, including genetic strategies, independent antibodies and antibody-independent measurements.
The appropriate approach depends on the target and model. A genetic perturbation can be informative, for example, but its effectiveness must be established. The goal is to assemble evidence that addresses plausible alternative explanations for the observed signal.
A useful distinction: “validated for Western blot in this model” is more informative than an unqualified claim that an antibody is “validated”.
07 / Controls address different sources of uncertainty
Controls should be chosen according to the question being tested. A secondary-only control examines contributions from the secondary detection system. A known positive sample can help assess whether the experimental workflow is capable of producing a signal.
Neither control alone establishes target specificity. A target-negative sample or an appropriate genetic strategy addresses a different uncertainty. Good experimental planning identifies which explanation each control can test and which uncertainties remain.
08 / Signal intensity is not a complete biological explanation
A brighter signal can reflect several factors, including target abundance, accessibility and detection conditions. Quantitative comparisons require consistent preparation, suitable acquisition settings and assessment of the measurement range.
Likewise, overlapping fluorescent signals do not by themselves demonstrate direct molecular interaction. A band near an expected molecular weight does not independently establish identity. These observations become stronger evidence when appropriate controls and complementary measurements support them.
09 / Select reagents using documented evidence
Begin with the target, species, sample and intended application. Then examine the antibody’s identity, immunogen information where available, application data and recommended conditions. For secondary reagents, include host matching, cross-adsorption requirements and detection compatibility.
A catalogue description is a starting point. Application-specific data and accessible documentation help determine whether a reagent is a reasonable candidate for evaluation. Browse our research products or request product documentation using the relevant reference.
10 / Connect immunodetection with the wider experiment
Immunodetection becomes especially useful when it connects molecular recognition with a biological hypothesis. Measuring a protein alongside its RNA, localisation or functional activity can reveal different aspects of a cellular response.
This perspective supports modern biotechnology by helping researchers characterise models, examine engineered proteins and develop assays. The central task remains to connect a specific signal with a justified experimental interpretation.
Scientific reference: Uhlen M et al. A proposal for validation of antibodies. Nature Methods. 2016;13:823–827. Read the original publication .
← Return to all scientific subjects